High Tower Advisors, LLC Dr Reddys Laboratories LTD Transaction History

High Tower Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$53.34 - $63.11 $1.48 Million - $1.75 Million	27,749 New	27,749 $1.75 Million
Q2 2020 Aug 10, 2020	SELL	$39.55 - $54.65 $1.57 Million - $2.17 Million	-39,756 Closed	0 $0
Q1 2020 May 21, 2020	BUY	$34.75 - $45.85 $1.38 Million - $1.82 Million	39,756 New	39,756 $1.61 Million
Q1 2019 May 15, 2019	SELL	$35.77 - $40.57 $290,845 - $329,874	-8,131 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$31.89 - $38.44 $259,297 - $312,555	8,131 New	8,131 $305,000

233

24M

14.6K

2.8K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $13.2B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.